Sandip Pravin Patel

23PUBLICATIONS
179CO-AUTHORS
NanomedicineMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 18, 2026
Safety and efficacy of intratumoral MEDI1191, an IL-12 mRNA lipid nanoparticle, plus intravenous durvalumab in patients with advanced solid tumors: a first-in-human study.

|Apr 17, 2026
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: vaginal cancer sub cohort results.

|Dec 11, 2025
Efficacy and CNS Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multicenter Basket Trial Analysis (NCI/SWOG S1609).

Manmeet S Ahluwalia, Sophie Solomon, Sandip P Patel

|Oct 21, 2025
Multicenter phase II trial of ipilimumab and nivolumab in metastatic or unresectable perivascular epithelioid cell tumor (PEComa): a substudy of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609 (Cohort 38).

Sandip P Patel, Megan Othus, Young K Chae

|Oct 15, 2025
Molecular Characterization of Oncogenic Gene Fusions in a Large Real-World Cohort of Solid Tumors.

Lisa Gai, Bradley Bowles, Adam J Hockenberry

|Aug 26, 2025
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024.

Narjust Florez, Sandip Patel, Heather A Wakelee

Pageof 4

Frequent Collaborators

9 joint publications

Young Kwang Chae

8 joint publications

Megan Othus

7 joint publications

Razelle Kurzrock

6 joint publications

Elad Sharon